热门资讯> 正文
Propanc Bizerma完成公开募股，向纳斯达克上市
2025-08-20 01:04
- Propanc Biopharma (NASDAQ:PPCB) on Tuesday said that it closed an underwritten public offering of 1,000,000 shares of its common stock, at $4.00 per share for gross proceeds of $4M.
- Shares began trading on NASDAQ Capital under ticker 'PPCB' on Aug 15, 2025.
- The Company has also granted the underwriter a 45-day option to purchase up to 150,000 additional shares of common stock at the public offering price, less underwriting discounts.
- The offering was closed on Aug 18, 2025.
- PPCB is -30.77% to $4.05
- Source: Press Release
More on Propanc Biopharma, Inc.
- Financial information for Propanc Biopharma, Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
